Labcorp Holdings (LH) is Trading at an Attractive Valuation
Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Labcorp Holdings Inc. (LH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 1,554,443 | $339,583,618 | +10% | 1.38% |
| 2. | Southpoint Capital Advisors John Smith Clark | 625,000 | $136,537,500 | -31% | 2.7% |
| 3. | Ariel Investments John W. Rogers | 544,574 | $118,967,636 | -2% | 1.17% |
| 4. | Citadel Investment Group Ken Griffin | 351,724 | $76,837,626 | -29% | 0.01% |
| 5. | Wallace R. Weitz & Co. Wallace Weitz | 256,350 | $56,002,221 | -2% | 2.82% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $231.20 | 44 | Officer | 14,282 | 2022-09-07 | Filing | |
| $242.19 | 42 | Officer | 14,172 | 2022-06-07 | Filing | |
| $264.57 | 600 | Director | 10,254 | 2022-02-16 | Filing | |
| $263.98 | 1,600 | Director | 9,654 | 2022-02-16 | Filing | |
| $262.85 | 1,300 | Director | 8,054 | 2022-02-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $210.84 | 200 | Officer | 5,637 | 2024-05-14 | Filing | |
| $210.83 | 1,800 | Officer | 5,837 | 2024-05-14 | Filing | |
| $200.10 | 250 | Director | 15,722 | 2024-05-02 | Filing | |
| $204.14 | 250 | Director | 15,972 | 2024-04-30 | Filing | |
| $204.33 | 2,439 | Officer | 2,087 | 2024-04-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,488,997 | $2,384,044,026 | 0.06% | |
| 2. | 9,745,657 | $2,215,090,380 | 0.04% | |
| 3. | 3,770,286 | $856,948,305 | 0.04% | |
| 4. | 2,248,093 | $510,969,058 | 0.09% | |
| 5. | 1,934,163 | $439,616,785 | 0.03% |
News See All
Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript
Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.68, expectations were $3.46.
Do You Think Laboratory Corporation of America Holdings (LH) Valuation is Not Attractive Anymore?
Vltava Fund, an investment management company, recently released its first-quarter 2024 investor letter. A copy of the same can be downloaded here.
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2023 Earnings Call Transcript
Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.3, expectations were $3.29.
Here’s How Vltava Fund Created Value Via Laboratory Corporation of America Holdings (LH) Spin-off
Vltava Fund, an investment management company, recently released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. 2023 proved to be a prosperous year for the fund.
Should You Invest in Laboratory Corporation of America Holdings (LH)?
Diamond Hill Capital, an investment management company, released its “Long-Short Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Laboratory Corporation of America Holdings Third Quarter 2023 Earnings Conference Call. At this time all participants are in listen only mode.
Laboratory Corporation of America Holdings (NYSE:LH) Q2 2023 Earnings Call Transcript
Operator: Good day. And thank you for standing by. Welcome to the Labcorp’s Second Quarter 2023 Earnings Conference Call.
Laboratory Corporation of America Holdings (NYSE:LH) Q1 2023 Earnings Call Transcript
Chas Cook: Thank you, operator. Good morning, and welcome to Labcorp’s first quarter 2023 conference call.
27 Largest Biotech Companies in the US
In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US.
Billionaire Hedge Funds
